Ancora in the News

MIT News Office: Ancora Pharmaceuticals takes top prize in $50K business plan contest
bNet: Surface Logix and Ancora Pharmaceuticals Awarded $6.9 Million NIST-ATP Grant to Develop New Drug Discovery Technologies Based On Carbohydrates
bNet: MIT Biomedical Innovation Forum to Address the Future of Vaccines and Central Nervous System Disorders Through the Lens of Personalized Medicine
Nano Science and Technology Institute: Harris & Harris Group Invests in Ancora Pharmaceuticals
Nanotechnology Now: Harris & Harris Group Invests in Ancora Pharmaceuticals
The Tech: Ancora Pharmaceuticals Triumphs in $50K Contest
Chemistry & Biology: Ancora Cooks with Carbs Synthesizing Carbohydrate Vaccines
Chemical & Engineering News: Founder Of Ancora Wins Korber Prize
Chemical & Engineering News: Carbohydrate Vaccines
Chemical & Engineering News: Preventing Malaria
Chemical & Engineering News: Carbohydrate Advances
Chemical & Engineering News: 2003 ACS Cope Award Winners
Chemical Biology: Interview with Peter Seeberger
Medical News Today: Potential Vaccine Developed For Deadly Leishmaniasis Disease
Mass High Tech: Ancora anchors drug plans with $2.2M in VC